Current Drug Targets
Volume 20, 16 Issues, 2019
ISSN: 1873-5592 (Online)
ISSN: 1389-4501 (Print)
This journal supports open access
ISSN: 1873-5592 (Online)
ISSN: 1389-4501 (Print)
This journal supports open access
Most Cited Articles
AMPK as a New Attractive Therapeutic Target for Disease Prevention: The Role of Dietary Compounds AMPK and Disease Prevention
, 2016; 17(8): 865-889.Massimiliano Gasparrini, Francesca Giampieri, Josè M. Alvarez Suarez, Luca Mazzoni, Tamara Y. Forbes Hernandez, Josè L. Quiles, Pedro Bullon and Maurizio Battino
DOI: 10.2174/1573399811666150615150235
B1-Metallo- β-Lactamases: Where Do We Stand?
, 2016; 17(9): 1029-1050.Maria F. Mojica, Robert A. Bonomo and Walter Fast
DOI: 10.2174/1389450116666151001105622
Efflux Pump Inhibitors: A Novel Approach to Combat Efflux-Mediated Drug Resistance in Bacteria
, 2016; 17(6): 702-719.Yinhu Wang, Henrietta Venter and Shutao Ma
DOI: 10.2174/1389450116666151001103948
Diabetes and Complications: Cellular Signaling Pathways, Current Understanding and Targeted Therapies
, 2016; 17(11): 1309-1328.Krishna A. Adeshara, Arundhati G. Diwan and Rashmi S. Tupe
DOI: 10.2174/1389450117666151209124007
Oxidative Stress and Antioxidants in Neurological Diseases: Is There Still Hope?
, 2017; 18(6): 705-718.Andreia Neves Carvalho*, Omidreza Firuzi, Maria Joao Gama, Jack van Horssen and Luciano Saso
DOI: 10.2174/1389450117666160401120514
Virological and Clinical Response to Interferon-Free Regimens in Patients with HCV-Related Mixed Cryoglobulinemia: Preliminary Results of a Prospective Pilot Study
, 2017; 18(7): 772-785.Laura Gragnani, Alessia Piluso, Teresa Urraro, Alessio Fabbrizzi, Elisa Fognani, Luisa Petraccia, Alessandro Genovesi, Lidia Giubilei, Jessica Ranieri, Cristina Stasi, Monica Monti and Anna Linda Zignego*
DOI: 10.2174/1389450117666160208145432
Structural and Functional Aspects of Class A Carbapenemases
, 2016; 17(9): 1006-1028.Thierry Naas, Laurent Dortet and Bogdan I. Iorga
DOI: 10.2174/1389450117666160310144501
Targeting Cystathionine Beta-Synthase Misfolding in Homocystinuria by Small Ligands: State of the Art and Future Directions
, 2016; 17(13): 1455-1470.Tomas Majtan, Angel L. Pey, June Ereño-Orbea, Luis Alfonso Martínez-Cruz and Jan P. Kraus
DOI: 10.2174/1389450117666160302094910
Sirtuins: Possible Clinical Implications in Cardio and Cerebrovascular Diseases
, 2017; 18(4): 473-484.Valeria Conti, Maurizio Forte, Graziamaria Corbi, Giusy Russomanno, Luigi Formisano, Alessandro Landolfi, Viviana Izzo, Amelia Filippelli, Carmine Vecchione and Albino Carrizzo
DOI: 10.2174/1389450116666151019095903
Biology, Epidemiology, Clinical Aspects of Hepatocellular Carcinoma and the Role of Sorafenib
, 2016; 17(7): 783-799.Gianluigi Mazzoccoli, Luca Miele, Jude Oben, Antonio Grieco and Manlio Vinciguerra
DOI: 10.2174/1389450117666151209120831
  |
Editor-in-Chief
Francis J. Castellino
Kleiderer-Pezold Professor of Biochemistry
Director, W.M. Keck Center for Transgene Research
Dean Emeritus, College of Science
230 Raclin-Carmichael Hall, University of Notre Dame
Notre Dame, IN 46556
USA
Kleiderer-Pezold Professor of Biochemistry
Director, W.M. Keck Center for Transgene Research
Dean Emeritus, College of Science
230 Raclin-Carmichael Hall, University of Notre Dame
Notre Dame, IN 46556
USA
About the Journal
For Authors
For Librarians & Readers
Journal History
Current Drug Targets Journal was launched in 2000. Dr. Francis J. Castellino serves as the Editor-in-Chief of the journal.
Webmaster Contact: info@benthamscience.net